Novartis Gets Positive Result From Breast-Cancer Drug Trial

By Cecilia Butini


Novartis AG said Monday that a trial evaluating breast-cancer drug Kisqali met its primary endpoint during an interim analysis.

The drug is shown to significantly reduce... | March 27, 2023

Related Keywords

Cecilia Butini ,Novartis ,Dow Jones ,Novartis Ag Stock Exchange ,News ,Information ,Press Release ,Y ,Cecilia ,Butini ,G ,Aid ,Monday ,Hat ,Trial ,Valuating ,Drug ,Kisqali ,Pet ,Its ,Primary ,Ndpoint ,During ,N ,Interim ,The ,Us ,Hown ,O ,Ignificantly Novn Ch0012005267 ,